Page last updated: 2024-09-03

peroxynitrous acid and Pulmonary Arterial Hypertension

peroxynitrous acid has been researched along with Pulmonary Arterial Hypertension in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baker, TM; Chen, YL; Daneva, Z; Goncharova, EA; Isakson, BE; Kasetti, RB; Kuppusamy, M; Laubach, VE; Marziano, C; Mihalek, AD; Minshall, RD; Ottolini, M; Reagan, CE; Shen, Y; Sonkusare, SK; Ta, HQ; Zhang, A; Zode, GS	1

Other Studies

1 other study(ies) available for peroxynitrous acid and Pulmonary Arterial Hypertension

Article	Year
Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension. Proceedings of the National Academy of Sciences of the United States of America, 2021, 04-27, Volume: 118, Issue:17 Topics: Animals; Arterial Pressure; Caveolae; Endothelium, Vascular; Humans; Mice, Knockout; NADPH Oxidase 1; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Protein Kinase C; Pulmonary Arterial Hypertension; TRPV Cation Channels	2021

Article

Year

Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension.

Proceedings of the National Academy of Sciences of the United States of America, 2021, 04-27, Volume: 118, Issue:17

Topics: Animals; Arterial Pressure; Caveolae; Endothelium, Vascular; Humans; Mice, Knockout; NADPH Oxidase 1; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Protein Kinase C; Pulmonary Arterial Hypertension; TRPV Cation Channels

2021